Potential for coronary CT angiography to tailor medical therapy beyond preventive guideline-based recommendations: Insights fromthe ROMICAT I trial

Journal of Cardiovascular Computed Tomography

Volumn 9, Issue 3, 2015, Pages 193-201

  Pursnani, Amit ^a,b   Schlett, Christopher L ^c   Mayrhofer, Thomas ^a   Celeng, Csilla ^a   Zakroysky, Pearl ^a   Bamberg, Fabian ^d   Nagurney, John T ^a   Truong, Quynh A ^a,e   Hoffmann, Udo ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b EVANSTON HOSPITAL   (United States)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Aspirin; Coronary artery disease; Coronary CT angiography; Guidelines; Prevention; Statin

Indexed keywords

ACETYLSALICYLIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ANTITHROMBOCYTIC AGENT;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; CARDIOVASCULAR RISK; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIMARY PREVENTION; PRIORITY JOURNAL; SECONDARY PREVENTION; THORAX PAIN; AGED; CLINICAL TRIAL; CORONARY ANGIOGRAPHY; DIAGNOSTIC IMAGING; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL EMERGENCY SERVICE; MASSACHUSETTS; MIDDLE AGED; PATIENT SELECTION; PREDICTIVE VALUE; PROCEDURES; PROTOCOL COMPLIANCE; SEVERITY OF ILLNESS INDEX; STANDARDS; X-RAY COMPUTED TOMOGRAPHY;

ACUTE CORONARY SYNDROME; ADULT; AGED; ASPIRIN; BOSTON; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; EMERGENCY SERVICE, HOSPITAL; FEMALE; GUIDELINE ADHERENCE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PATIENT ADMISSION; PATIENT DISCHARGE; PATIENT SELECTION; PLATELET AGGREGATION INHIBITORS; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; PRIMARY PREVENTION; SECONDARY PREVENTION; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84929047110     PISSN: 19345925     EISSN: 1876861X     Source Type: Journal    
DOI: 10.1016/j.jcct.2015.02.006     Document Type: Article

References (35)

1. Hoffmann U., Bamberg F., Chae C.U., et al. Coronary computed tomography angiography for early triage of patients with acute chest pain: the ROMICAT (Rule Out Myocardial Infarction using Computer Assisted Tomography) trial. JAm Coll Cardiol 2009, 53(18):1642-1650.
2. Hoffmann U., Truong Q.A., Schoenfeld D.A., et al. Coronary CT angiography versus standard evaluation in acute chest pain. NEngl J Med 2012, 367(4):299-308.
3. Goldstein J.A., Chinnaiyan K.M., Abidov A., et al. The CT-STAT (Coronary Computed Tomographic Angiography for Systematic Triage of Acute Chest Pain Patients to Treatment) trial. JAm Coll Cardiol 2011, 58(14):1414-1422.
4. Bamberg F., Marcus R.P., Schlett C.L., et al. Imaging evaluation of acute chest pain: systematic review of evidence base and cost-effectiveness. JThorac Imaging 2012, 27(5):289-295.
5. Budoff M.J., Dowe D., Jollis J.G., et al. Diagnostic performance of 64-multidetector row coronary computed tomographic angiography for evaluation of coronary artery stenosis in individuals without known coronary artery disease: results from the prospective multicenter ACCURACY (Assessment by Coronary Computed Tomographic Angiography of Individuals Undergoing Invasive Coronary Angiography) trial. JAm Coll Cardiol 2008, 52(21):1724-1732.
6. Miller J.M., Rochitte C.E., Dewey M., et al. Diagnostic performance of coronary angiography by 64-row CT. NEngl J Med 2008, 359(22):2324-2336.
7. Ostrom M.P., Gopal A., Ahmadi N., et al. Mortality incidence and the severity of coronary atherosclerosis assessed by computed tomography angiography. JAm Coll Cardiol 2008, 52(16):1335-1343.
8. Min J.K., Shaw L.J., Devereux R.B., et al. Prognostic value of multidetector coronary computed tomographic angiography for prediction of all-cause mortality. JAm Coll Cardiol 2007, 50(12):1161-1170.
9. Chow B.J., Small G., Yam Y., et al. Incremental prognostic value of cardiac computed tomography in coronary artery disease using CONFIRM: COroNary computed tomography angiography evaluation for clinical outcomes: an InteRnational Multicenter registry. Circ Cardiovasc Imaging 2011, 4(5):463-472.
10. Ahmadi N., Nabavi V., Hajsadeghi F., et al. Mortality incidence of patients with non-obstructive coronary artery disease diagnosed by computed tomography angiography. Am J Cardiol 2011, 107:10-16.
11. Hadamitzky M., Distler R., Meyer T., et al. Prognostic value of coronary computed tomographic angiography in comparison with calcium scoring and clinical risk scores. Circ Cardiovasc Imaging 2011, 4:16-23.
12. Pundziute G., Schuijf J.D., Jukema J.W. Prognostic value of multislice computed tomography coronary angiography in patients with known or suspected coronary artery disease. JAm Coll Cardiol 2007, 49:62-70.
13. Schlett C.L., Banerji D., Siegel E., et al. Prognostic value of CT angiography for major adverse cardiac events in patients with acute chest pain from the emergency department: 2-year outcomes of the ROMICAT trial. JACC Cardiovasc Imaging 2011, 4:481-491.
14. van Werkhoven J.M., Schuijf J.D., Gaemperli O., et al. Prognostic value of multislice computed tomography and gated single-photon emission computed tomography in patients with suspected coronary artery disease. JAm Coll Cardiol 2009, 53:623-632.
15. Bamberg F., Sommer W.H., Hoffmann V., et al. Meta-analysis and systematic review of the long-term predictive value of assessment of coronary atherosclerosis by contrast-enhanced coronary computed tomography angiography. JAm Coll Cardiol 2011, 57:2426-2436.
16. Hulten E.A., Carbonaro S., Petrillo S.P., Mitchell J.D., Villines T.C. Prognostic value of cardiac computed tomography angiography: a systematic review and meta-analysis. JAm Coll Cardiol 2011, 57:1237-1247.
17. Smith S.C., Allen J., Blair S.N., et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 2006, 113(19):2363-2372.
18. Antman E.M., Hand M., Armstrong P.W., et al. 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee. Circulation 2008, 117(2):296-329.
19. Smith S.C., Benjamin E.J., Bonow R.O., et al. AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation 2011, 124(22):2458-2473.
20. Anderson J.L., Adams C.D., Antman E.M., et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation 2007, 116(7):e148-e304.
21. Pearson T.A., Blair S.N., Daniels S.R., et al. AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation 2002, 106(3):388-391.
22. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002, 106(25):3143-3421.
23. Grundy S.M., Cleeman J.I., Merz C.N., et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. JAm Coll Cardiol 2004, 44(3):720-732.
24. Colwell J.A. Aspirin therapy in diabetes. Diabetes Care 2004, 27(Suppl 1):S72-S73.
25. Hayden M., Pignone M., Phillips C., Mulrow C. Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002, 136(2):161-172.
26. Aspirin for the primary prevention of cardiovascular events: recommendation and rationale. Ann Intern Med 2002, 136(2):157-160.
27. Miedema M.D., Duprez D.A., Misialek J.R., et al. Use of coronary artery calcium testing to guide aspirin utilization for primary prevention: estimates from the multi-ethnic study of atherosclerosis. Circ Cardiovasc Qual Outcomes 2014, 7(3):453-460.
28. Taylor A.J., Bindeman J., Feuerstein I., et al. Community-based provision of statin and aspirin after the detection of coronary artery calcium within a community-based screening cohort. JAm Coll Cardiol 2008, 51(14):1337-1341.
29. Arad Y., Spadaro L.A., Roth M., Newstein D., Guerci A.D. Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E: the St. Francis Heart Study randomized clinical trial. JAm Coll Cardiol 2005, 46(1):166-172.
30. McEvoy J.W., Blaha M.J., Nasir K., et al. Impact of coronary computed tomographic angiography results on patient and physician behavior in a low-risk population. Arch Intern Med 2011, 171(14):1260-1268.
31. LaBounty T.M., Devereux R.B., Lin F.Y., Weinsaft J.W., Min J.K. Impact of coronary computed tomographic angiography findings on the medical treatment and control of coronary artery disease and its risk factors. Am J Cardiol 2009, 104(7):873-877.
32. Cheezum M.K., Hulten E.A., Smith R.M., et al. Changes in preventive medical therapies and CV risk factors after CT angiography. JACC Cardiovasc Imaging 2013, 6:574-581.
33. Hulten E., Bittencourt M.S., Singh A., et al. Coronary artery disease detected by coronary computed tomographic angiography is associated with intensification of preventive medical therapy and lower low-density lipoprotein cholesterol. Circ Cardiovasc Imaging 2014, 7(4):629-638.
34. Hachamovitch R., Nutter B., Hlatky M.A., et al. Patient management after noninvasive cardiac imaging results from SPARC (Study of myocardial perfusion and coronary anatomy imaging roles in coronary artery disease). JAm Coll Cardiol 2012, 59(5):462-474.
35. Maddox T.M., Ho P.M., Roe M., Dai D., Tsai T.T., Rumsfeld J.S. Utilization of secondary prevention therapies in patients with nonobstructive coronary artery disease identified during cardiac catheterization: insights from the National Cardiovascular Data Registry Cath-PCI Registry. Circ Cardiovasc Qual Outcomes 2010, 3(6):632-641.